INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 448m ago
House PTR48m ago
SEC 13F47m ago
Robinhood Chain47m ago

Results

82,053 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
RC
Raub ChristopherExecutive Vice President
JXNJackson Financial Inc.
Grant or award
A—
4,179 sh
Feb 2, 2026Feb 4, 2026
Page 1613 of 2052
← PrevNext →
traded Feb 2, 2026
+2d
SEC Form 4

Evidence

21
SK
Shaikh KashifDirector, President and CEO
PENGPenguin Solutions, Inc.
Grant or award
A—
137.9K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
GC
Gutman CarrieSenior Vice President
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
1,620 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

21
KA
Kleczynski Robert ASVP, Controller & Tax
EXCEXELON CORP
Option exercise
M—
2,110 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
RD
Ruppel DavidSVP & GM Transportation Bus.
LFUSLITTELFUSE INC /DE
Option exercise
M—
1,113 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
GF
Ghingo John FDirector, President
HRLHORMEL FOODS CORP /DE/
Grant or award
A—
32.7K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
JM
Jones Jeanne MEVP, CFO, Audit & Risk
EXCEXELON CORP
Option exercise
M—
7,031 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
HD
Honorable Colette DEVP CLO Compliance & Corp Sec
EXCEXELON CORP
Option exercise
M—
4,781 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
RH
Robbins Edward Hutchinson Jr.EVP, General Counsel
TLSTELOS CORP
Grant or award
A—
270.4K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

21
SN
Smith NathanChief Financial Officer
CDNACareDx, Inc.
Grant or award
A—
33.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

20
DM
Detz Margaret MasonerChief People Officer
CABOCable One, Inc.
Grant or award
A$125K
1,422 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

20
SJ
Schladen JamesPresident of Arcadia
BOOMDMC Global Inc.
Tax withholding
F$69K
8,053 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

20
KM
Koetje Todd MSee Remarks.
CABOCable One, Inc.
Grant or award
A$193K
2,198 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

20
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$127K
7,039 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

20
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$4.35M
247.1K sh
Feb 4, 2026Feb 4, 2026
traded Feb 4, 2026
+0dSEC Form 4

Evidence

19
FN
France NatashaSEE REMARKS
AMPYAmplify Energy Corp.
Option exercise
M—
10.4K sh
Feb 1, 2026Feb 4, 2026
traded Feb 1, 2026
+3dSEC Form 4

Evidence

19
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Grant or award
A$27K
818 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

19
JM
Jones Jeanne MEVP, CFO, Audit & Risk
EXCEXELON CORP
Disposition to issuer
D$314K
7,154 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
DD
Duffy Kristine DDirector
AROWARROW FINANCIAL CORP
Grant or award
A$27K
818 sh
Jan 28, 2026Feb 4, 2026
traded Jan 28, 2026
+7dSEC Form 4

Evidence

19
MD
Metzfield DennisVP, PAO & Controller
BAHBooz Allen Hamilton Holding Corp
Tax withholding
F$20K
229 sh
Jan 30, 2026Feb 4, 2026
traded Jan 30, 2026
+5dSEC Form 4

Evidence

19
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$106K
720 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$186K
1,233 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$187K
4,064 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

19
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$378K
1,639 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

18
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Open-market sale · 10b5-1 plan
SELL$3.80M
52.6K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
146.5K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
MC
Malabre Richard CSVP, Chief Accounting Officer
AKBAAkebia Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
36.1K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
RC
Raub ChristopherExecutive Vice President
JXNJackson Financial Inc.
Grant or award
A—
11.2K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
JM
Jones Jeanne MEVP, CFO, Audit & Risk
EXCEXELON CORP
Option exercise
M—
24.7K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$18
1 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

17
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
14.1K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Grant or award
A—
483.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
25.9K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
GC
Gutman CarrieSenior Vice President
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
763 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

17
HK
Hill Donna K.VP, Human Resources
TLSTELOS CORP
Grant or award
A—
17.1K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
850 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$140K
600 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
CE
Clark Kyra ESenior Vice President
LKFNLAKELAND FINANCIAL CORP
Tax withholding
F$63K
1,045 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
FD
Frost DianaDirector
WWayfair Inc.
Tax withholding
F$57K
548 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

16
SN
Smith NathanChief Financial Officer
CDNACareDx, Inc.
Tax withholding
F$79K
3,859 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence